Ryuta Inoue
Sapporo, 0608556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Neuregulin-1-β1 and γ-secretase play a critical role in sphere-formation and cell survival of urothelial carcinoma cancer stem-like cells.
Journal: Biochemical and biophysical research communications
Published: March 04, 2021
Incidence and risk factors of postoperative delirium in elderly patients undergoing urological surgery: A multi-institutional prospective study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: July 14, 2019
Serum testosterone level is a useful biomarker for determining the optimal treatment for castration-resistant prostate cancer.
Journal: Urologic oncology
Published: December 25, 2018
Ureteral calculi secondary to a gradually migrated acupuncture needle.
Journal: Asian journal of urology
Published: March 19, 2018
GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
Journal: Oncotarget
Published: June 29, 2016
Dosing Schedules and Outcomes in Patients Treated with First-Line Sunitinib for Advanced Renal Cell Carcinoma
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: May 25, 2016
CLINICAL FEATURES OF 15 PATIENTS UNDER SURVEILLANCE FOR RENAL MASSES.
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 01, 2016
Prognostic factors and efficacy of molecular targeted therapy for metastatic clear cell renal cell carcinoma
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: June 04, 2015
Expression of hepatocyte growth factor in prostate cancer may indicate a biochemical recurrence after radical prostatectomy.
Journal: Anticancer research
Published: January 01, 2015
Clinical and pathological features of the best candidates for active surveillance-retrospective analysis of patients with radical prostatectomy
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: October 12, 2013
Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer--results from phase I clinical trials.
Journal: Clinical & developmental immunology
Published: August 05, 2013
Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: September 03, 2012
Last Updated: 09/26/2026